WO2001087305A3 - Method for treating functional dyspepsia using alosetron - Google Patents
Method for treating functional dyspepsia using alosetron Download PDFInfo
- Publication number
- WO2001087305A3 WO2001087305A3 PCT/US2001/015633 US0115633W WO0187305A3 WO 2001087305 A3 WO2001087305 A3 WO 2001087305A3 US 0115633 W US0115633 W US 0115633W WO 0187305 A3 WO0187305 A3 WO 0187305A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- alosetron
- functional dyspepsia
- treating functional
- treating
- dyspepsia
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01935516A EP1284732A2 (en) | 2000-05-18 | 2001-05-15 | Method for treating functional dyspepsia using alosetron |
JP2001583773A JP2003533482A (en) | 2000-05-18 | 2001-05-15 | How to treat functional dyspepsia |
AU2001261606A AU2001261606A1 (en) | 2000-05-18 | 2001-05-15 | Method for treating functional dyspepsia |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20530800P | 2000-05-18 | 2000-05-18 | |
US60/205,308 | 2000-05-18 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001087305A2 WO2001087305A2 (en) | 2001-11-22 |
WO2001087305A3 true WO2001087305A3 (en) | 2002-04-25 |
Family
ID=22761668
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/015633 WO2001087305A2 (en) | 2000-05-18 | 2001-05-15 | Method for treating functional dyspepsia using alosetron |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1284732A2 (en) |
JP (1) | JP2003533482A (en) |
AU (1) | AU2001261606A1 (en) |
WO (1) | WO2001087305A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003100091A1 (en) * | 2002-05-24 | 2003-12-04 | Epidauros Biotechnologie Ag | Means and methods for improved treatment using 'setrones' |
US7820690B2 (en) | 2004-03-19 | 2010-10-26 | Solvay Pharmaceuticals Gmbh | Method of treating or inhibiting a non-digestive tract derived abdominal disorder associated with pain using a 5-HT, receptor antagonist |
JP2007529476A (en) * | 2004-03-19 | 2007-10-25 | ゾルファイ ファーマスーティカルズ ゲゼルシャフト ミット ベシュレンクテル ハフツング | Use of 5-HT3 receptor antagonist in the manufacture of a medicament for the treatment of painful abdominal diseases derived from non-gastrointestinal tract |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0485962A2 (en) * | 1990-11-16 | 1992-05-20 | Syntex (U.S.A.) Inc. | New tricyclic compounds |
EP0490263A1 (en) * | 1990-12-07 | 1992-06-17 | Syntex (U.S.A.) Inc. | Alpha-oxoacetamide derivatives |
US5202333A (en) * | 1989-11-28 | 1993-04-13 | Syntex (U.S.A.) Inc. | Tricyclic 5-HT3 receptor antagonists |
US5516782A (en) * | 1991-03-07 | 1996-05-14 | G. D. Searle & Co. | New meso-azacyclic aromatic acid amides and esters as novel serotonergic agents |
WO1999017755A2 (en) * | 1997-10-07 | 1999-04-15 | Glaxo Group Limited | Medicaments |
WO2001041748A2 (en) * | 1999-12-10 | 2001-06-14 | Novartis Ag | Pharmaceutical combinations and their use in treating gastrointestinal disorders |
WO2001045685A2 (en) * | 1999-12-20 | 2001-06-28 | Glaxo Group Limited | Formulations of adenosine a1 agonists |
-
2001
- 2001-05-15 AU AU2001261606A patent/AU2001261606A1/en not_active Abandoned
- 2001-05-15 WO PCT/US2001/015633 patent/WO2001087305A2/en not_active Application Discontinuation
- 2001-05-15 EP EP01935516A patent/EP1284732A2/en not_active Withdrawn
- 2001-05-15 JP JP2001583773A patent/JP2003533482A/en active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5202333A (en) * | 1989-11-28 | 1993-04-13 | Syntex (U.S.A.) Inc. | Tricyclic 5-HT3 receptor antagonists |
EP0485962A2 (en) * | 1990-11-16 | 1992-05-20 | Syntex (U.S.A.) Inc. | New tricyclic compounds |
EP0490263A1 (en) * | 1990-12-07 | 1992-06-17 | Syntex (U.S.A.) Inc. | Alpha-oxoacetamide derivatives |
US5516782A (en) * | 1991-03-07 | 1996-05-14 | G. D. Searle & Co. | New meso-azacyclic aromatic acid amides and esters as novel serotonergic agents |
WO1999017755A2 (en) * | 1997-10-07 | 1999-04-15 | Glaxo Group Limited | Medicaments |
WO2001041748A2 (en) * | 1999-12-10 | 2001-06-14 | Novartis Ag | Pharmaceutical combinations and their use in treating gastrointestinal disorders |
WO2001045685A2 (en) * | 1999-12-20 | 2001-06-28 | Glaxo Group Limited | Formulations of adenosine a1 agonists |
Non-Patent Citations (3)
Title |
---|
COULIE B. ET AL: "New therapies for functional bowel disease.", CURRENT GASTROENTEROLOGY REPORTS, vol. 2, 2000, pages 355 - 363, XP001041929 * |
GUPTA Y.K. ET AL.: "Therapeutic potentials of 5-HT receptor modulators", INDIAN JOURNAL OF PHARMACOLOGY, vol. 26, 1994, pages 94 - 107, XP001041938 * |
MAXTON D.G. ET AL.: "Selective 5-hydroxytryptamine antagonism: a role in irritable bowel syndrome and functional dyspepsia?", ALIMENT. PHARMACOL. THER., vol. 10, 1996, pages 595 - 599, XP001041947 * |
Also Published As
Publication number | Publication date |
---|---|
AU2001261606A1 (en) | 2001-11-26 |
WO2001087305A2 (en) | 2001-11-22 |
JP2003533482A (en) | 2003-11-11 |
EP1284732A2 (en) | 2003-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001060347A3 (en) | Method for treating ocular pain | |
AU2002325835A1 (en) | Treatment method, which promotes the removal of dirt, for the surfaces of textiles and non-textiles | |
PL364995A1 (en) | Method for the treatment or prevention of flavivirus | |
AU2001249881A1 (en) | Method of treating the heart | |
AU2002215125A1 (en) | Well treatment method | |
GB0014969D0 (en) | Novel method of treatment | |
AU2003247624A8 (en) | Method of treating the syndrome of lipodystrophy | |
AU2001239858A1 (en) | Wastewater treatment process | |
MXPA03001717A (en) | Method for treatment of migraine. | |
EP1465968A4 (en) | Methods for treating deodorizer distillate | |
HK1064261A1 (en) | Method for the treatment of tobacco. | |
AU2001286983A1 (en) | Method of treatment | |
AU2001285747A1 (en) | Method for the treatment of tobacco | |
AU2001273609A1 (en) | Process for treating wood | |
MXPA03006607A (en) | Combined method for treating hormono-dependent disorders. | |
EP1667827A4 (en) | Process for the treatment of wood | |
MXPA03003347A (en) | Method of purifying plavastatin. | |
AU2001244834A1 (en) | Novel strain for decomposing tmah, and method of wastewater treatment using the same | |
MXPA03004017A (en) | Method for the treatment of inflammation. | |
WO2001087305A3 (en) | Method for treating functional dyspepsia using alosetron | |
AU2002236116A1 (en) | Method to treat soapy wastewater | |
GB0026838D0 (en) | Treatment method | |
AU2001262177A1 (en) | Method of treatment | |
HK1059391A1 (en) | Use of quetiapine for the treatment of cocaine dependence | |
AU2001235776A1 (en) | Apparatus and method for water treatment by adsorption |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 10276238 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001935516 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2001935516 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2001935516 Country of ref document: EP |